−4.10 USD
−116.61 M USD
7.17 M USD
8.26 M
About RELIEF THERAPEUTICS N
Sector
Headquarters
Geneva
Founded
2013
Website
ISIN
CH1251125998
FIGI
BBG00T1PXR85
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RLFTF is 4.50 USD — it has decreased by −8.16% in the past 24 hours. Watch RELIEF THERAPEUTICS HLDG AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RELIEF THERAPEUTICS HLDG AG stocks are traded under the ticker RLFTF.
RLFTF stock has risen by 3.21% compared to the previous week, the month change is a −13.75% fall, over the last year RELIEF THERAPEUTICS HLDG AG has showed a 133.16% increase.
RLFTF reached its all-time high on Aug 6, 2020 with the price of 380.00 USD, and its all-time low was 1.10 USD and was reached on Aug 23, 2024. View more price dynamics on RLFTF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RLFTF stock is 12.64% volatile and has beta coefficient of −1.90. Track RELIEF THERAPEUTICS HLDG AG stock price on the chart and check out the list of the most volatile stocks — is RELIEF THERAPEUTICS HLDG AG there?
Today RELIEF THERAPEUTICS HLDG AG has the market capitalization of 56.21 M, it has increased by 16.84% over the last week.
Yes, you can track RELIEF THERAPEUTICS HLDG AG financials in yearly and quarterly reports right on TradingView.
RLFTF net income for the last half-year is −5.07 M USD, while the previous report showed −49.51 M USD of net income which accounts for 89.76% change. Track more RELIEF THERAPEUTICS HLDG AG financial stats to get the full picture.
No, RLFTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RELIEF THERAPEUTICS HLDG AG EBITDA is −10.30 M USD, and current EBITDA margin is −274.92%. See more stats in RELIEF THERAPEUTICS HLDG AG financial statements.
Like other stocks, RLFTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTICS HLDG AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RELIEF THERAPEUTICS HLDG AG technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RELIEF THERAPEUTICS HLDG AG stock shows the sell signal. See more of RELIEF THERAPEUTICS HLDG AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.